Essex Woodlands Fund IX-GP, L.P.
10% Owner

Essex Woodlands Fund IX-GP, L.P. insider trades: EyePoint Pharmaceuticals (EYPT) stock buys and sales

10% Owner, EyePoint Pharmaceuticals Last trade Sep 1, 2023 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2018
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Essex Woodlands Fund IX-GP, L.P. reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2023EYPT↓ Sell$198K
Aug 31, 2023EYPT↓ Sell$1.5M
Aug 29, 2023EYPT↓ Sell$1.7M
Aug 25, 2023EYPT↓ Sell$3.0M
Aug 23, 2023EYPT↓ Sell$2.3M
Dec 15, 2021VERO↑ Buy$4.7M
Dec 15, 2021VERO↑ Buy$190K
Jun 25, 2018EYPT↑ Buy$20.5M
Jun 25, 2018EYPT↑ Buy$825K
Mar 28, 2018PSDV↑ Buy$9.1M
Mar 28, 2018PSDV↑ Buy$366K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EYPT insiders

Open-market trades in the last 12 months

About Essex Woodlands Fund IX-GP, L.P.'s insider trades

Essex Woodlands Fund IX-GP, L.P. is a 10% owner of EyePoint Pharmaceuticals (EYPT). Since Mar 28, 2018, it has reported 6 open-market purchases worth $35.7M and 5 sales worth $8.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (8 filings), conversions (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EYPT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.